154 related articles for article (PubMed ID: 36175970)
1. Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis.
Ziółkowski P; Woźniak M; Mansour A; An Y; Weber GF
Breast Cancer Res; 2022 Sep; 24(1):64. PubMed ID: 36175970
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis.
Walaszek K; Lower EE; Ziolkowski P; Weber GF
Br J Cancer; 2018 Nov; 119(10):1259-1266. PubMed ID: 30353046
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.
Hao C; Wang Z; Gu Y; Jiang WG; Cheng S
Biomed Res Int; 2016; 2016():7310694. PubMed ID: 27462610
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Osteopontin splice variants in cancer.
An Y; Fnu G; Xie C; Weber GF
BMC Cancer; 2023 Apr; 23(1):373. PubMed ID: 37095438
[TBL] [Abstract][Full Text] [Related]
7. The osteopontin-c splice junction is important for anchorage-independent growth.
Shen H; Weber GF
Mol Carcinog; 2014 Jun; 53(6):480-7. PubMed ID: 23359517
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin expression in a group of lymph node negative breast cancer patients.
Tuck AB; O'Malley FP; Singhal H; Harris JF; Tonkin KS; Kerkvliet N; Saad Z; Doig GS; Chambers AF
Int J Cancer; 1998 Oct; 79(5):502-8. PubMed ID: 9761120
[TBL] [Abstract][Full Text] [Related]
9. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin splice variants are differential predictors of breast cancer treatment responses.
Zduniak K; Agrawal A; Agrawal S; Hossain MM; Ziolkowski P; Weber GF
BMC Cancer; 2016 Jul; 16():441. PubMed ID: 27400751
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
13. [Expression of osteopontin splice variant and its clinical significance in gastric cancer].
Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of osteopontin in calcified breast tissue.
Huan JL; Xing L; Qin XJ; Gao ZG; Pan XF; Zhao ZD
Asian Pac J Cancer Prev; 2012; 13(10):5219-23. PubMed ID: 23244138
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.
Butti R; Nimma R; Kundu G; Bulbule A; Kumar TVS; Gunasekaran VP; Tomar D; Kumar D; Mane A; Gill SS; Patil T; Weber GF; Kundu GC
Oncogene; 2021 Mar; 40(11):2002-2017. PubMed ID: 33603163
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin expression profiles predict pathological and clinical outcome in breast cancer.
Patani N; Jouhra F; Jiang W; Mokbel K
Anticancer Res; 2008; 28(6B):4105-10. PubMed ID: 19192668
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells.
El-Tanani MK; Yuen HF; Shi Z; Platt-Higgins A; Buckley NE; Mullan PB; Harkin DP; Johnston PG; Rudland PS
Cancer Sci; 2010 Jun; 101(6):1354-60. PubMed ID: 20384635
[TBL] [Abstract][Full Text] [Related]
18. Conditional Knockdown of Osteopontin Inhibits Breast Cancer Skeletal Metastasis.
Kovacheva M; Zepp M; Schraad M; Berger S; Berger MR
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590218
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
20. The elevated expression of osteopontin and vascular endothelial growth factor in sinonasal inverted papilloma and its relationship with clinical severity.
Liu W; Li Z; Luo Q; Lai Y; Zhang J; Chen F; Shi J; Li H; Xiong G; Xu G; Wang H
Am J Rhinol Allergy; 2011; 25(5):313-7. PubMed ID: 22186244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
